GlassScriptPhysician profile
Joseph W Basler
NPI 1801802566
$2,539.74
in general payments reported to CMS, 2019-2025
10 companies · $724 in 2025
The $724 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $466 · 2021: $134 · 2022: $437 · 2023: $353 · 2024: $427 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,503.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,503.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $675.45 | 2019-2025 | Lithovue, Ams 700 |
| Janssen Biotech, INC. | $529.71 | 2019-2025 | Rybrevant, Carvykti, Erleada |
| Coloplast Corp | $427.77 | 2019-2024 | Speedicath |
| Ethicon US, LLC | $289.47 | 2021-2024 | Stratafix, Echelon; Endopath, Dermabond |
| Cook Medical LLC | $182.89 | 2019-2023 | Cook |
| Endo Pharmaceuticals INC. | $122.13 | 2022 | |
| Medtronic, INC. | $121.96 | 2022 | |
| Antares Pharma, INC. | $100.62 | 2023 | Tlando, Xyosted |
| Ambu INC. | $49.75 | 2024 | |
| Heron Therapeutics, INC. | $39.99 | 2022-2023 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Basler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.